These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 38864473)
21. Ultrasound-based Radiomics Analysis for Assessing Risk Factors Associated With Early Recurrence Following Surgical Resection of Hepatocellular Carcinoma. Cao K; Wang X; Xu C; Wu L; Li L; Yuan Y; Ye X Ultrasound Med Biol; 2024 Dec; 50(12):1964-1972. PubMed ID: 39332987 [TBL] [Abstract][Full Text] [Related]
22. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy. Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809 [TBL] [Abstract][Full Text] [Related]
23. Deep learning algorithm-based multimodal MRI radiomics and pathomics data improve prediction of bone metastases in primary prostate cancer. Zhang YF; Zhou C; Guo S; Wang C; Yang J; Yang ZJ; Wang R; Zhang X; Zhou FH J Cancer Res Clin Oncol; 2024 Feb; 150(2):78. PubMed ID: 38316655 [TBL] [Abstract][Full Text] [Related]
24. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation. Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650 [TBL] [Abstract][Full Text] [Related]
25. A radiomics-based model can predict recurrence-free survival of hepatocellular carcinoma after curative ablation. Peng W; Jiang X; Zhang W; Hu J; Zhang Y; Zhang L Asian J Surg; 2023 Jul; 46(7):2689-2696. PubMed ID: 36351862 [TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study. Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163 [TBL] [Abstract][Full Text] [Related]
27. Prediction of preoperative microvascular invasion by dynamic radiomic analysis based on contrast-enhanced computed tomography. Zhou Z; Xia T; Zhang T; Du M; Zhong J; Huang Y; Xuan K; Xu G; Wan Z; Ju S; Xu J Abdom Radiol (NY); 2024 Feb; 49(2):611-624. PubMed ID: 38051358 [TBL] [Abstract][Full Text] [Related]
28. Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma. Zhu HB; Zheng ZY; Zhao H; Zhang J; Zhu H; Li YH; Dong ZY; Xiao LS; Kuang JJ; Zhang XL; Liu L Diagn Interv Radiol; 2020 Sep; 26(5):411-419. PubMed ID: 32490826 [TBL] [Abstract][Full Text] [Related]
29. Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection. Li N; Wan X; Zhang H; Zhang Z; Guo Y; Hong D BMC Cancer; 2022 Jun; 22(1):664. PubMed ID: 35715783 [TBL] [Abstract][Full Text] [Related]
30. Deep learning radiomics based on contrast enhanced computed tomography predicts microvascular invasion and survival outcome in early stage hepatocellular carcinoma. Yang Y; Zhou Y; Zhou C; Ma X Eur J Surg Oncol; 2022 May; 48(5):1068-1077. PubMed ID: 34862094 [TBL] [Abstract][Full Text] [Related]
31. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969 [TBL] [Abstract][Full Text] [Related]
32. Risk Factors for Early Recurrence After Radical Resection of Hepatocellular Carcinoma Based on Preoperative Contrast-Enhanced Ultrasound and Clinical Features. Cao K; Wu L; Wang X; Deng H; Yuan Y; Li L; Xu C; Ye X Technol Cancer Res Treat; 2024; 23():15330338241281327. PubMed ID: 39212079 [TBL] [Abstract][Full Text] [Related]
33. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. Ning P; Gao F; Hai J; Wu M; Chen J; Zhu S; Wang M; Shi D Abdom Radiol (NY); 2020 Jan; 45(1):64-72. PubMed ID: 31486869 [TBL] [Abstract][Full Text] [Related]
34. [Value of the application of enhanced CT radiomics and machine learning in preoperative prediction of microvascular invasion in hepatocellular carcinoma]. Yu YX; Hu CH; Wang XM; Fan YF; Hu MJ; Shi C; Hu S; Zhu M; Zhang Y Zhonghua Yi Xue Za Zhi; 2021 May; 101(17):1239-1245. PubMed ID: 34865392 [No Abstract] [Full Text] [Related]
35. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning. Saito A; Toyoda H; Kobayashi M; Koiwa Y; Fujii H; Fujita K; Maeda A; Kaneoka Y; Hazama S; Nagano H; Mirza AH; Graf HP; Cosatto E; Murakami Y; Kuroda M Mod Pathol; 2021 Feb; 34(2):417-425. PubMed ID: 32948835 [TBL] [Abstract][Full Text] [Related]
36. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. Zhu WS; Shi SY; Yang ZH; Song C; Shen J World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424 [TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553 [TBL] [Abstract][Full Text] [Related]
38. Machine learning-based radiomics analysis of preoperative functional liver reserve with MRI and CT image. Zhu L; Wang F; Chen X; Dong Q; Xia N; Chen J; Li Z; Zhu C BMC Med Imaging; 2023 Jul; 23(1):94. PubMed ID: 37460944 [TBL] [Abstract][Full Text] [Related]
39. Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation. Ma QP; He XL; Li K; Wang JF; Zeng QJ; Xu EJ; He XQ; Li SY; Kun W; Zheng RQ; Tian J Mol Imaging Biol; 2021 Aug; 23(4):572-585. PubMed ID: 33483803 [TBL] [Abstract][Full Text] [Related]
40. A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma. Cai W; He B; Hu M; Zhang W; Xiao D; Yu H; Song Q; Xiang N; Yang J; He S; Huang Y; Huang W; Jia F; Fang C Surg Oncol; 2019 Mar; 28():78-85. PubMed ID: 30851917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]